vs
Omada Health, Inc.（OMDA）与P3 Health Partners Inc.（PIII）财务数据对比。点击上方公司名可切换其他公司
P3 Health Partners Inc.的季度营收约是Omada Health, Inc.的5.7倍（$384.8M vs $68.0M）。Omada Health, Inc.净利率更高（-4.7% vs -19.6%，领先15.0%）
Omada Health是美国头部数字化慢性病管理服务商，面向雇主、商业健康保险机构及医疗系统，提供针对2型糖尿病、高血压、肌肉骨骼疾病、心理健康等领域的个性化干预方案，搭配专业教练指导和数字化工具，助力用户改善长期健康水平。
P3 Health Partners Inc.是一家总部位于美国的人口健康管理与价值型医疗服务企业，与基层医疗机构及医疗系统合作，为包括联邦医保优势计划参保者在内的人群提供协同优质医疗服务，致力于提升诊疗效果、降低不必要的医疗开支。
OMDA vs PIII — 直观对比
营收规模更大
PIII
是对方的5.7倍
$68.0M
净利率更高
OMDA
高出15.0%
-19.6%
损益表 — Q3 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $68.0M | $384.8M |
| 净利润 | $-3.2M | $-75.5M |
| 毛利率 | 66.3% | — |
| 营业利润率 | -3.7% | -40.0% |
| 净利率 | -4.7% | -19.6% |
| 营收同比 | — | 3.8% |
| 净利润同比 | — | -28.8% |
| 每股收益（稀释后） | $-0.06 | $-23.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OMDAPIII
| Q4 25 | — | $384.8M | ||
| Q3 25 | $68.0M | $345.3M | ||
| Q2 25 | $61.4M | $355.8M | ||
| Q1 25 | — | $373.2M | ||
| Q4 24 | — | $370.7M | ||
| Q3 24 | — | $362.1M | ||
| Q2 24 | — | $379.2M | ||
| Q1 24 | — | $388.5M |
净利润OMDAPIII
| Q4 25 | — | $-75.5M | ||
| Q3 25 | $-3.2M | $-31.6M | ||
| Q2 25 | $-5.3M | $-20.4M | ||
| Q1 25 | — | $-20.5M | ||
| Q4 24 | — | $-58.6M | ||
| Q3 24 | — | $-46.5M | ||
| Q2 24 | — | $-12.0M | ||
| Q1 24 | — | $-18.7M |
毛利率OMDAPIII
| Q4 25 | — | — | ||
| Q3 25 | 66.3% | — | ||
| Q2 25 | 65.7% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率OMDAPIII
| Q4 25 | — | -40.0% | ||
| Q3 25 | -3.7% | -12.8% | ||
| Q2 25 | -7.1% | -9.6% | ||
| Q1 25 | — | -10.2% | ||
| Q4 24 | — | -37.4% | ||
| Q3 24 | — | -29.5% | ||
| Q2 24 | — | -8.3% | ||
| Q1 24 | — | -11.3% |
净利率OMDAPIII
| Q4 25 | — | -19.6% | ||
| Q3 25 | -4.7% | -9.1% | ||
| Q2 25 | -8.7% | -5.7% | ||
| Q1 25 | — | -5.5% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -12.8% | ||
| Q2 24 | — | -3.2% | ||
| Q1 24 | — | -4.8% |
每股收益（稀释后）OMDAPIII
| Q4 25 | — | $-23.08 | ||
| Q3 25 | $-0.06 | $-9.67 | ||
| Q2 25 | $-0.24 | $-6.23 | ||
| Q1 25 | — | $-6.28 | ||
| Q4 24 | — | $-23.13 | ||
| Q3 24 | — | $-15.70 | ||
| Q2 24 | — | $-7.37 | ||
| Q1 24 | — | $-7.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.6M | $25.0M |
| 总债务越低越好 | $0 | $228.4M |
| 股东权益账面价值 | $217.3M | $-155.2M |
| 总资产 | $287.5M | $656.6M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资OMDAPIII
| Q4 25 | — | $25.0M | ||
| Q3 25 | $198.6M | $37.7M | ||
| Q2 25 | $223.1M | $38.6M | ||
| Q1 25 | — | $40.1M | ||
| Q4 24 | — | $38.8M | ||
| Q3 24 | — | $63.0M | ||
| Q2 24 | — | $73.1M | ||
| Q1 24 | — | $27.3M |
总债务OMDAPIII
| Q4 25 | — | $228.4M | ||
| Q3 25 | $0 | $252.8M | ||
| Q2 25 | $30.0M | $182.0M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | — | $108.9M | ||
| Q3 24 | — | $133.2M | ||
| Q2 24 | — | $133.1M | ||
| Q1 24 | — | $118.1M |
股东权益OMDAPIII
| Q4 25 | — | $-155.2M | ||
| Q3 25 | $217.3M | $-18.7M | ||
| Q2 25 | $214.2M | $44.5M | ||
| Q1 25 | — | $63.3M | ||
| Q4 24 | — | $75.9M | ||
| Q3 24 | — | $120.5M | ||
| Q2 24 | — | $166.8M | ||
| Q1 24 | — | $146.6M |
总资产OMDAPIII
| Q4 25 | — | $656.6M | ||
| Q3 25 | $287.5M | $683.6M | ||
| Q2 25 | $303.0M | $731.6M | ||
| Q1 25 | — | $783.9M | ||
| Q4 24 | — | $783.4M | ||
| Q3 24 | — | $833.3M | ||
| Q2 24 | — | $892.8M | ||
| Q1 24 | — | $855.9M |
负债/权益比OMDAPIII
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.14× | 4.09× | ||
| Q1 25 | — | 2.71× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 1.11× | ||
| Q2 24 | — | 0.80× | ||
| Q1 24 | — | 0.81× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $10.1M | $-25.7M |
| 自由现金流经营现金流 - 资本支出 | $9.6M | — |
| 自由现金流率自由现金流/营收 | 14.1% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流OMDAPIII
| Q4 25 | — | $-25.7M | ||
| Q3 25 | $10.1M | $-15.4M | ||
| Q2 25 | $-13.3M | $-16.6M | ||
| Q1 25 | — | $-33.5M | ||
| Q4 24 | — | $-57.2M | ||
| Q3 24 | — | $-22.6M | ||
| Q2 24 | — | $-10.2M | ||
| Q1 24 | — | $-20.0M |
自由现金流OMDAPIII
| Q4 25 | — | — | ||
| Q3 25 | $9.6M | — | ||
| Q2 25 | $-13.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率OMDAPIII
| Q4 25 | — | — | ||
| Q3 25 | 14.1% | — | ||
| Q2 25 | -22.6% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度OMDAPIII
| Q4 25 | — | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OMDA
| Services | $62.9M | 93% |
| Hardware | $5.1M | 7% |
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
